Compounds > pyridostigmine bromide
Page last updated: 2024-08-18

pyridostigmine bromide and Central Nervous System Disease

pyridostigmine bromide has been researched along with Central Nervous System Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bealer, SL; Dudek, FE; Pouliot, W; Roach, B1
Fusek, J; Kassa, J1
Beldowicz, D; Guo, W; Natelson, BH; Ottenweller, JE; Servatius, RJ; Zhu, G1
Ben Nathan, D; Danenberg, HD; Grauer, E; Kapon, J; Kobiler, D; Lustig, S1
Zheng, W1
Gilbert, JC1

Reviews

1 review(s) available for pyridostigmine bromide and Central Nervous System Disease

ArticleYear
Neurotoxicology of the brain barrier system: new implications.
    Journal of toxicology. Clinical toxicology, 2001, Volume: 39, Issue:7

    Topics: Aluminum; Animals; Blood-Brain Barrier; Central Nervous System Diseases; Cyclosporine; Humans; Lead; Manganese Poisoning; MPTP Poisoning; N-Methylaspartate; Nitro Compounds; Nitrobenzenes; Propionates; Pyridostigmine Bromide; Xenobiotics

2001

Other Studies

5 other study(ies) available for pyridostigmine bromide and Central Nervous System Disease

ArticleYear
A rodent model of human organophosphate exposure producing status epilepticus and neuropathology.
    Neurotoxicology, 2016, Volume: 56

    Topics: Animals; Antidotes; Atropine; Central Nervous System Diseases; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Male; Organophosphates; Phosphoric Triester Hydrolases; Pralidoxime Compounds; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Status Epilepticus

2016
Effect of Panpal pretreatment and antidotal treatment (HI-6 plus benactyzine) on respiratory and circulatory function in soman-poisoned rats.
    Human & experimental toxicology, 1997, Volume: 16, Issue:10

    Topics: Acetylcholinesterase; Animals; Antidotes; Benactyzine; Blood Pressure; Brain; Central Nervous System Diseases; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Diaphragm; Drug Therapy, Combination; Electrocardiography; Heart Rate; Male; Oximes; Pyridinium Compounds; Pyridostigmine Bromide; Rats; Rats, Wistar; Respiration; Soman; Trihexyphenidyl

1997
Persistently exaggerated startle responses in rats treated with pyridostigmine bromide.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:3

    Topics: Animals; Butyrylcholinesterase; Central Nervous System Diseases; Cholinesterase Inhibitors; Humans; Male; Motor Activity; Pain Threshold; Parasympathomimetics; Persian Gulf Syndrome; Pyridostigmine Bromide; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Reflex, Startle; Time Factors

1998
Viral neuroinvasion as a marker for BBB integrity following exposure to cholinesterase inhibitors.
    Life sciences, 2001, Jan-19, Volume: 68, Issue:9

    Topics: Alphavirus Infections; Animals; Blood-Brain Barrier; Brain; Central Nervous System Diseases; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Female; Lethal Dose 50; Mice; Mice, Inbred ICR; Permeability; Physostigmine; Pyridostigmine Bromide; Sindbis Virus; Soman; Viremia

2001
Diseases of the central nervous system. Pharmacological basis of treatment.
    British medical journal, 1975, Oct-04, Volume: 4, Issue:5987

    Topics: Amantadine; Analgesics, Opioid; Anticonvulsants; Blood-Brain Barrier; Central Nervous System Diseases; Cholinesterase Inhibitors; Edrophonium; Epilepsy; Headache; Humans; Levodopa; Methysergide; Migraine Disorders; Myasthenia Gravis; Parkinson Disease; Pyridostigmine Bromide; Serotonin Antagonists

1975